CorMedix Inc (NYSE MKT LLC:CRMD)

1.88
Data as of 4:02pm ET
 +0.1095 / +6.18%
Today’s Change
0.66
Today|||52-Week Range
3.20
+51.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$39.0M

Company Description

CorMedix, Inc. is a development stage pharmaceutical and medical device company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas. The company's products are Neutrolin CRMD003, Thixotropic Gel CRMD004, Deferiprone CRMD001 and Urine Catalytic Test CRMD002. CorMedix was founded on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
745 Route 202-206
Bridgewater New Jersey 08807
P:(908) 517-9500
Investor Relations:
(908) 517-9489

Employees

Shareholders

Other institutional14.52%
Individual stakeholders11.22%
Mutual fund holders1.70%

Top Executives

Randy D. MilbyCEO, Director & Head-Media Relations
Harry O'GradyChief Financial Officer
Antony E. PfaffleVice Chairman, Secretary & CSO
William J. VanjonackVice President-Manufacturing & Quality Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.